<DOC>
	<DOCNO>NCT02481102</DOCNO>
	<brief_summary>The objective Registry provide post market clinical outcome potential health economics data confirm continue safety EpiAccess system .</brief_summary>
	<brief_title>EASYER ( EpiAccess SYstem Registry ) A Post Market Observational Registry</brief_title>
	<detailed_description>The Registry prospective non-randomized single-arm trial 150 patient enrol ten ( 10 ) center United States . The overall duration registry estimate 18 month per site . For patient registry duration time procedure discharge hospital , estimate approximately four ( 4 ) day . Prior enrollment , patient evaluate basis late available data establish eligibility . Eligible patient consider enrolled registry write informed consent obtain . As EpiAccess use access portion procedure , safety performance effectiveness endpoint acute time needle insertion pericardial sac access achieve . Follow clinical examination perform accord institutional standard care . No special test require device .</detailed_description>
	<mesh_term>Arrhythmias , Cardiac</mesh_term>
	<criteria>Patient 18 year age older Pericardial access clinically indicated Patient willing able provide write informed consent Patients condition contraindicate pericardial access condition specify Contraindications section Instructions Use . This include : Previous cardiac surgery myocardial infarction result pericardial fibrosis Congenital absence pericardium Absence free epicardial space Patients active infection History chronic pericarditis Patient require antiarrhythmic drug therapy treatment ventricular arrhythmia Patient normal sinus rhythm Presence thrombus leave atrium Coagulopathy Known allergy contrast medium</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>